EA200601512A1 - Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат - Google Patents

Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат

Info

Publication number
EA200601512A1
EA200601512A1 EA200601512A EA200601512A EA200601512A1 EA 200601512 A1 EA200601512 A1 EA 200601512A1 EA 200601512 A EA200601512 A EA 200601512A EA 200601512 A EA200601512 A EA 200601512A EA 200601512 A1 EA200601512 A1 EA 200601512A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
azabiccal
contain
new
production
Prior art date
Application number
EA200601512A
Other languages
English (en)
Other versions
EA010300B1 (ru
Inventor
Патрик Касара
Анне-Мари Шолле
Ален Дено
Льонель Берт
Пьер Лестаж
Брайан Локхарт
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200601512A1 publication Critical patent/EA200601512A1/ru
Publication of EA010300B1 publication Critical patent/EA010300B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к соединениям формулы (I)в которой m и n, которые могут быть одинаковыми или разными, каждый представляет собой целое число от 0 до 2 включительно, где сумма двух целых чисел составляет от 2 до 3 включительно, р и q, которые могут быть одинаковыми или разными, каждый представляет собой целое число от 0 до 2 включительно, Alk представляет собой алкиленовую, алкениленовую или алкиниленовую цепь, Х представляет собой атом кислорода, атом серы или -N(R)-группу, где R представляет собой атом водорода или алкильную группу, Y, Y' и W имеют значения, указанные в описании, их энантиомеры, диастереоизомеры, а также их соли присоединения с одной или несколькими фармацевтически приемлемой кислотой или основанием. Лекарственные средства.
EA200601512A 2004-02-20 2005-02-18 Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат EA010300B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0401690A FR2866647B1 (fr) 2004-02-20 2004-02-20 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2005/000382 WO2005089747A1 (fr) 2004-02-20 2005-02-18 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA200601512A1 true EA200601512A1 (ru) 2007-02-27
EA010300B1 EA010300B1 (ru) 2008-08-29

Family

ID=34833930

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601512A EA010300B1 (ru) 2004-02-20 2005-02-18 Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат

Country Status (30)

Country Link
US (1) US7576120B2 (ru)
EP (1) EP1720544B1 (ru)
JP (1) JP4519861B2 (ru)
KR (1) KR100885104B1 (ru)
CN (2) CN101230033B (ru)
AR (3) AR047685A1 (ru)
AT (1) ATE389398T1 (ru)
AU (1) AU2005224129B2 (ru)
BR (1) BRPI0507830A (ru)
CA (1) CA2555216C (ru)
CY (1) CY1108529T1 (ru)
DE (1) DE602005005456T2 (ru)
DK (1) DK1720544T3 (ru)
EA (1) EA010300B1 (ru)
ES (1) ES2303233T3 (ru)
FR (1) FR2866647B1 (ru)
GE (1) GEP20094578B (ru)
HK (1) HK1123789A1 (ru)
HR (1) HRP20080184T5 (ru)
MA (1) MA28342A1 (ru)
ME (1) ME01400B (ru)
MY (1) MY137282A (ru)
NO (1) NO337013B1 (ru)
NZ (1) NZ548898A (ru)
PL (1) PL1720544T3 (ru)
PT (1) PT1720544E (ru)
RS (1) RS50577B (ru)
SI (1) SI1720544T1 (ru)
WO (1) WO2005089747A1 (ru)
ZA (1) ZA200606558B (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717234A1 (en) * 2005-04-29 2006-11-02 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
WO2008116145A2 (en) * 2007-03-22 2008-09-25 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
FR2932479A1 (fr) * 2008-06-13 2009-12-18 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953514B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953515B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953513B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-6-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2953521B1 (fr) 2009-12-09 2011-11-18 Servier Lab Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2974729B1 (fr) 2011-05-02 2013-04-19 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent
FR2976285B1 (fr) 2011-06-08 2013-05-24 Servier Lab Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent
FR2976286B1 (fr) 2011-06-08 2013-05-24 Servier Lab 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
TWI555741B (zh) 2011-12-08 2016-11-01 大正製藥股份有限公司 Phenylpyrrole derivatives
FR2983732B1 (fr) * 2011-12-09 2013-11-22 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent
WO2013100054A1 (ja) * 2011-12-27 2013-07-04 大正製薬株式会社 フェニルトリアゾール誘導体
CN103183632A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种3-氮杂双环辛烷盐酸盐的提纯方法
FR2999179A1 (fr) * 2012-12-07 2014-06-13 Servier Lab Procede de synthese d'un sel d'addition a un acide pharmaceutiquement acceptable du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, ainsi que les formes cristallines associees
FR3003466B1 (fr) * 2013-03-22 2015-08-07 Servier Lab Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
EP3594206A1 (en) * 2018-07-09 2020-01-15 Abivax Phenyl-n-quinoline derivatives for treating a rna virus infection
EP3594205A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
CN111377911B (zh) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 一种吗啉苯甲酰胺类化合物及其应用
CN111377846B (zh) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 一种哌嗪苯甲酰胺类衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962496A (en) * 1957-01-28 1960-11-29 Geschickter Fund Med Res Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
ATE314343T1 (de) * 2000-06-30 2006-01-15 Elan Pharm Inc Verbindungen zur behandlung der alzheimerischen krankheit
EP1301480B1 (en) * 2000-07-13 2007-09-12 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
FR2827288B1 (fr) * 2001-07-12 2003-10-31 Servier Lab Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO337013B1 (no) 2015-12-21
RS50577B (sr) 2010-05-07
EA010300B1 (ru) 2008-08-29
CA2555216C (fr) 2011-10-11
HRP20080184T5 (en) 2008-10-31
AR094601A2 (es) 2015-08-12
EP1720544A1 (fr) 2006-11-15
CN100577160C (zh) 2010-01-06
MY137282A (en) 2009-01-30
NO20064160L (no) 2006-09-14
AR047685A1 (es) 2006-02-01
DE602005005456D1 (de) 2008-04-30
DE602005005456T2 (de) 2009-04-09
AR089451A2 (es) 2014-08-27
CN1921848A (zh) 2007-02-28
DK1720544T3 (da) 2008-07-21
MA28342A1 (fr) 2006-12-01
CN101230033A (zh) 2008-07-30
SI1720544T1 (sl) 2008-06-30
GEP20094578B (en) 2009-01-12
PL1720544T3 (pl) 2008-05-30
CY1108529T1 (el) 2014-04-09
BRPI0507830A (pt) 2007-07-10
AU2005224129B2 (en) 2010-08-12
FR2866647A1 (fr) 2005-08-26
FR2866647B1 (fr) 2006-10-27
PT1720544E (pt) 2008-05-08
ZA200606558B (en) 2008-01-08
ME01400B (en) 2013-12-20
CN101230033B (zh) 2011-03-09
US20070197625A1 (en) 2007-08-23
JP2007523135A (ja) 2007-08-16
JP4519861B2 (ja) 2010-08-04
EP1720544B1 (fr) 2008-03-19
HRP20080184T3 (en) 2008-05-31
HK1123789A1 (en) 2009-06-26
KR100885104B1 (ko) 2009-02-20
CA2555216A1 (fr) 2005-09-29
ATE389398T1 (de) 2008-04-15
KR20060114382A (ko) 2006-11-06
NZ548898A (en) 2010-06-25
US7576120B2 (en) 2009-08-18
AU2005224129A1 (en) 2005-09-29
ES2303233T3 (es) 2008-08-01
WO2005089747A1 (fr) 2005-09-29

Similar Documents

Publication Publication Date Title
EA200601512A1 (ru) Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат
NO20040945L (no) Benzotiepin ileal gallesyre transport inhibitorer
UY27431A1 (es) Compuestos químicos
HUP0200100A2 (hu) Eljárások és készítmények a fehérvérsejtek számának fokozására
NO20032829D0 (no) Kjemiske forbindelser
HUP0204235A2 (hu) Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0400246A2 (hu) 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
FR2809396B1 (fr) Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
EA200500690A1 (ru) Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат
RU2011105810A (ru) Азотсодержащие бициклические гетероциклические соединения
EA200500717A1 (ru) Новые соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат
EA200501526A1 (ru) Производные 4-замещённых хинолинов, способ и промежуточные продукты для их получения и содержащие их фармацевтические композиции
EA200500683A1 (ru) Новые соединения пирролидина и тиазолидина, способ их получения и фармацевтические композиции, которые их содержат
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
RU2003130070A (ru) Производные бигуанида
CA2364864A1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions phamaceutiques qui les contiennent
HUP0303020A2 (hu) Androgén 7-szubsztituált 11-halogénezett szteroidok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
EA200600551A1 (ru) Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат
DK0732332T3 (da) Substituerede benzothienylpiperaziner, deres anvendelse som lægemidler og fremgangsmåder til fremstilling deraf
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
EA200200665A1 (ru) Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU